» Articles » PMID: 21486906

Antigen Specificity of Immune Suppression by Myeloid-derived Suppressor Cells

Overview
Journal J Leukoc Biol
Date 2011 Apr 14
PMID 21486906
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Among the mechanisms set in motion by the tumor to escape the control of the immune system, MDSCs play a central role in inducing tolerance to a variety of anti-tumor effectors, including T lymphocytes. It has been demonstrated that MDSCs expand in tumor-bearing mice and in cancer patients, leading to an impairment of T cell reactivity against the tumor. However, as the presence of MDSCs is not correlated with a general immune suppression, it was advanced that a mechanism regulating the specificity of MDSC inhibition must be present. In this article, we review the literature showing that MDSCs exert their immune-suppressive function on Ag-specific T cell responses but at times, also on mitogen-activated T lymphocytes, therefore bypassing the Ag dependency. We propose that the features of MDSC-mediated immune suppression might be influenced not only by the specific microenvironment in which MDSCs expand and by the tumor characteristics but also by the levels of activation of the target lymphocytes.

Citing Articles

Identification and Validation of Tumor Microenvironment-Associated Signature in Clear-Cell Renal Cell Carcinoma through Integration of DNA Methylation and Gene Expression.

Ye Z, Xu J, Zhang X, Zhang Y, Ivanova D, Lu W Int J Mol Sci. 2024; 25(12).

PMID: 38928496 PMC: 11203551. DOI: 10.3390/ijms25126792.


Identification of Key Genes Associated with Tumor Microenvironment Infiltration and Survival in Gastric Adenocarcinoma via Bioinformatics Analysis.

Konstantis G, Tsaousi G, Pourzitaki C, Kasper-Virchow S, Zaun G, Kitsikidou E Cancers (Basel). 2024; 16(7).

PMID: 38610959 PMC: 11010876. DOI: 10.3390/cancers16071280.


Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy.

Huang Y, Fan H, Ti H Asian J Pharm Sci. 2024; 19(2):100902.

PMID: 38595331 PMC: 11002556. DOI: 10.1016/j.ajps.2024.100902.


Nanosphere pharmacodynamics improves safety of immunostimulatory cytokine therapy.

Lacinski R, Dziadowicz S, Stewart A, Chaharbakhshi E, Akhter H, Pisquiy J iScience. 2024; 27(2):108836.

PMID: 38303687 PMC: 10831265. DOI: 10.1016/j.isci.2024.108836.


G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition.

Wang Y, Liu H, Zhang Z, Bian D, Shao K, Wang S J Immunother Cancer. 2023; 11(6).

PMID: 37364932 PMC: 10410840. DOI: 10.1136/jitc-2022-006166.